Ausgabe 9/2014
Inhalt (9 Artikel)
Hospital-Based Health Technology Assessment: Developments to Date
Marie-Pierre Gagnon
HTA Agencies Facing Model Biases: The Case of Type 2 Diabetes
Véronique Raimond, Jean-Michel Josselin, Lise Rochaix
The Burden of Disease in Rheumatoid Arthritis
Till Uhlig, Rikke H. Moe, Tore K. Kvien
Model-Based Cost-Effectiveness Analyses for the Treatment of Chronic Myeloid Leukaemia: A Review and Summary of Challenges
Kevin Marsh, Peng Xu, Panagiotis Orfanos, Agnes Benedict, Kamal Desai, Ingolf Griebsch
The Economic Burden of Head and Neck Cancer: A Systematic Literature Review
Erika Wissinger, Ingolf Griebsch, Juliane Lungershausen, Talia Foster, Chris L. Pashos
Discrete Choice Experiments in Health Economics: A Review of the Literature
Michael D. Clark, Domino Determann, Stavros Petrou, Domenico Moro, Esther W. de Bekker-Grob
Cost Effectiveness of Darunavir/ritonavir Combination Antiretroviral Therapy for Treatment-Naive Adults with HIV-1 Infection in Canada
Anita J. Brogan, Erik Smets, Josephine A. Mauskopf, Sarah A. L. Manuel, Ines Adriaenssen
Pharmacoeconomic Evaluation of Dabigatran, Rivaroxaban and Apixaban versus Enoxaparin for the Prevention of Venous Thromboembolism After Total Hip or Knee Replacement in Spain
Antonio Gómez-Outes, Cristina Avendaño-Solá, Ana Isabel Terleira-Fernández, Emilio Vargas-Castrillón